Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22
Open Access
- 1 January 2022
- journal article
- research article
- Published by XMLink in Immune Network
- Vol. 22 (3) , e26
Abstract
Kim S, et al. Immune Netw. 2022 Mar;22(3):e26. https://doi.org/10.4110/in.2022.22.e26Keywords
Funding Information
- National Research Foundation of Korea (2019R1I1A3A01047208, 2019R1I1A1A01058773, 2020R1A2B5B02001552, 2020R1A5A8019180, 2020R1I1A1A01069947)
- Kangwon National University (520190031)
This publication has 61 references indexed in Scilit:
- Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancerClinical Immunology, 2013
- An Automatic Refolding Apparatus for Preparative-Scale Protein ProductionPLOS ONE, 2012
- Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal TractGastroenterology, 2011
- STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healingJournal of Experimental Medicine, 2009
- Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel DiseaseImmunity, 2008
- Structure of IL-22 Bound to Its High-Affinity IL-22R1 ChainStructure, 2008
- Interleukin-22 Forms Dimers that are Recognized by Two Interleukin-22R1 Receptor ChainsBiophysical Journal, 2008
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammationJournal of Clinical Investigation, 2008
- IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitisJournal of Clinical Investigation, 2008
- Ulcerative colitis: diagnosis and managementBMJ, 2006